What is ChemoGLO?
ChemoGLO specializes in the detection, monitoring, and removal of hazardous drugs, offering innovative products such as the ChemoGLO Wipe Kit and HDClean Wipes. Their core objective is to enhance safety for patients and healthcare professionals by mitigating hazardous drug contamination risks within clinical, laboratory, and institutional environments. Leveraging over 25 years of experience in the cancer field, ChemoGLO's founders prioritize expertise, rapid customer service, and ongoing product innovation to empower users in accurately measuring contamination and establishing secure work settings.
How much funding has ChemoGLO raised?
ChemoGLO has raised a total of $78K across 1 funding round:
Debt
$78K
Debt (2021): $78K with participation from PPP
What's next for ChemoGLO?
With significant Series B/C stage investment, ChemoGLO is poised for accelerated growth and market penetration. The recent capital injection of $78K is earmarked for substantial expansion, likely involving scaling manufacturing capabilities, broadening distribution channels, and potentially investing in further research and development to enhance their hazardous drug safety portfolio. This strategic financing will enable ChemoGLO to solidify its position as a leader in ensuring safer environments against hazardous drug exposure.
See full ChemoGLO company page
